iKang Adopts Poison Pill Plan To Thwart Meinian Bid

Login to View

NASDAQ-listed iKang Healthcare Group has adopted a poison pill plan to thwart a higher and competing take-private bid from rival Meinian Onehealth Healthcare (Group) Co., Ltd., according to an announcement.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in

Join China Money Network for $89 a month